Home Diagnostics, Inc. v. J&J Lifescan
This article was originally published in The Gray Sheet
Executive Summary
U.S. Court of Appeals for the Federal Circuit in Washington, D.C. rules that Home Diagnostics' Prestige glucose monitor did not infringe on patents held by Johnson & Johnson subsidiary Lifescan. April 6 decision upholds earlier finding by U.S. District Court in Wilmington, Delaware. Home Diagnostics pulled the Prestige product from the market in November 1999 and has since introduced the Prestige LX, which uses a significantly different technology from the earlier version, the firm says (1"The Gray Sheet" July 3, 2000, p. 17)